Articles by Daniel Marsh
Moutai Shares Drop 2.6% as Liquor Sector Retreats Ahead of Inflation Data
Kweichow Moutai's Class A shares declined 2.6% to 1,515.01 yuan on Friday, leading a broad pullback in baijiu stocks. Investors are now focused on China's upcoming inflation figures for market direction.
CCB Shares Edge Higher as Markets Await Key Chinese Economic Data
China Construction Bank's Class A stock closed slightly higher on Friday, while the broader Shanghai market declined. Investor focus now shifts to upcoming inflation and credit data for policy direction.
Morgan Stanley Rebounds as Dow Tops 50,000; Focus Shifts to Fed Policy and AI Spending
Morgan Stanley shares gained 2.34% to $179.96 on Friday, ending a three-day decline amid broader market strength. The Dow Jones Industrial Average closed above 50,000 for the first time.
Nestle Shares Gain Amid Formula Recall Scrutiny, Investors Eye Upcoming Earnings
Nestle shares rose 0.6% to 78.89 Swiss francs, outperforming the Swiss market index as investors monitor a widening infant formula recall and await full-year results due February 19.
Goldman Sachs Surges on AI Partnership, Lifts Dow Past 50,000
Goldman Sachs shares climbed 4.3% Friday following confirmation of an AI collaboration with Anthropic, helping propel the Dow Jones Industrial Average above 50,000 for the first time. Key economic data releases and new structured note filings are in focus.
IBM Shares Surge 3% Ahead of Key Confluent Vote and Dividend Date
IBM stock climbed 3.1% to $298.93 on Friday, buoyed by a new defense contract and anticipation of upcoming shareholder events. The gain outpaced several tech peers as markets rebounded.
Novartis Advances with Canadian Reimbursement and Major U.S. R&D Expansion
Novartis shares gained as the company secured a draft reimbursement nod in Canada for Kisqali and broke ground on a $23 billion U.S. research center. Investors eye upcoming dividend and annual meeting.
Wells Fargo Rises 2.6% to $93.97 Amid Market Rebound, Eyes on Data and Conference
Wells Fargo shares gained 2.63% to close at $93.97 on Friday, trading ex-dividend for a $0.45 payout. Investors await key economic reports and a CFO presentation next week.
Merck Shares Approach 52-Week High on Canadian RSV Drug Approval
Merck stock gained 1.8% after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140, while insider sales were disclosed.
HSBC Shares Rebound as Bank of England Rate Cut Speculation Intensifies Ahead of Earnings
HSBC shares rose 2.2% on Friday, recovering from the previous session's decline as markets assess potential Bank of England policy easing. Investors await the bank's annual results on February 25.
LVMH Shares Drift Lower Ahead of Key U.S. Economic Data Releases
LVMH stock closed at €536.20, down 0.37%, as markets await delayed U.S. jobs and inflation reports next week. The luxury giant reported 497.7 million shares outstanding as of January 31.